Boya Biopharmaceutical Group Co., Ltd. Recruitment information, what about Boya Biopharmaceutical Group Co., Ltd.

Data source: The following information comes from the enterprise credit reporting agency. For more detailed enterprise risk data, please refer to official website and Company Profile, which can be found in the nailed enterprise code. For more company recruitment information, please consult the company official website in detail.

Company profile:

Boya Biopharmaceutical Group Co., Ltd. was established in1993-1-06 with a registered capital of 433,324.863 million yuan and its legal representative is Liao Xinxi. The company address is No.333 Huiquan Road, Fuzhou High-tech Industrial Development Zone, Fuzhou City, Jiangxi Province. The unified social credit code and tax number are 913610007277556904, the industry is manufacturing, the registration authority is Fuzhou Municipal Bureau of Market and Quality Supervision, and the business scope is blood products production (the license is valid until 65438+February 3, 20201). Engaged in the export business of self-produced products and related technologies of this enterprise and its member enterprises (except for commodities whose export is restricted or prohibited), the import business of raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies required for production and scientific research of this enterprise and its member enterprises (except for commodities whose import is restricted or prohibited by the state), the feed processing, "three supplies and one supplement" business, technology development and technical consultation, technology transfer and technical services of this enterprise (except for special provisions of national laws and regulations). The industrial and commercial registration number of Boya Biopharmaceutical Group Co., Ltd. is 3610001kloc-0/000915.

Branch:

Boya Biopharmaceutical Group Co., Ltd. Technology Center, with the registration number of 36100012000187 and the unified social credit code of 91310007277556904.

Foreign investment:

Fuzhou Boxin Pharmaceutical Technology Development Co., Ltd., the legal representative is Liang Xiaoming, the date of investment is 20 18-06-27, and the enterprise is in business, with a registered capital of 500.00000000, and the proportion of investment is 100.00%.

Jiangxi Boya Pharmaceutical Investment Co., Ltd., the legal representative is Liao Xinxi, the date of investment is 2013-1-28, the enterprise status is opening, the registered capital is 25,000.000000, and the investment ratio is 100.00%.

Tianjin Gaotejia Haihe Yifu Health Industry Investment Partnership (Limited Partnership), the legal representative is Beijing Gaotejia Asset Management Co., Ltd. (designated representative: Zhang), the investment date is 2017-12-15, the enterprise status is in operation (opening), and the registered capital is/kloc-0.

Jinxi Boya plasmapheresis Co., Ltd., the legal representative of which is Bai Qiang, was invested on May 2008-12, and the enterprise status is business (opening), with a registered capital of 445.00000000 and a contribution ratio of 100.00%.

Duchang county Boya plasmapheresis Co., Ltd., the legal representative is Lin Wensheng, the date of contribution is 20 16-0 1-20, the enterprise status is business (opening), the registered capital is 1000.000000, and the contribution ratio is 100.00%.

Shenzhen Gaote Jiaruibao Investment Partnership (Limited Partnership), the legal representative is, the date of investment is 20 17-09-26, the enterprise status is in operation (opening), the registered capital is 2 100.000000, and the investment ratio is 95.24%.

Beijing Boya Cigna Biotechnology Co., Ltd., the legal representative is Liang Xiaoming, the date of investment is 20 13-05-3 1, the enterprise status is business (opening), the registered capital is 1000.00000, and the investment ratio is 100.00%.

Jiangxi Boya Investment Management Co., Ltd., the legal representative is Xu Jianxin, the date of contribution is 2006-0 1-04, and the enterprise is cancelled as a legal person, with a registered capital of 400.00000000, and the contribution ratio is 100.00%.

Ganzhou Nankang Boya plasmapheresis Co., Ltd., with legal representative Sun Chen, was established by investment on May 25th, 2007. The state of the enterprise is in business, with a registered capital of 383.0000000 yuan and a contribution ratio of 100.00%.

Guangdong Dafu Pharmaceutical Co., Ltd., the legal representative of which is Liu Jianguo, was invested on June-10, 2002, and the enterprise was in the state of opening, with a registered capital of 8000.0000000, with a contribution ratio of 75.00%.

Zhuji Gaotejia Ruian Investment Partnership (Limited Partnership), legal representative Wang Haijiao, date of investment is 20 16-09-07, enterprise status is in operation (opening), registered capital is 60400.000000, and the contribution ratio is 8.28%.

Nanjing Xinbai Pharmaceutical Co., Ltd., the legal representative is Shen Fei, the date of investment is 200 1-03-28, the enterprise status is operation (opening), the registered capital is 14785.000000, and the proportion of investment is 100.00%.

Fengcheng plasmapheresis co., ltd, the legal representative is ge, the date of investment is 20 15-0 1-07, the enterprise status is in business (opening), the registered capital is 1000.000000, and the investment ratio is 100.00%.

Nanjing Boya Pharmaceutical Co., Ltd., legal representative Zhang Shifang, was invested on February 2, 2007, and the enterprise was in the state of opening, with a registered capital of 500.00000000, and the contribution ratio was 100.00%.

Yuechi Boya plasmapheresis Co., Ltd., the legal representative of which is Nathan Chen, was invested on 20 10-08-24, and the enterprise was in business, with a registered capital of 500.00000000 and a contribution ratio of 100.00%.

Chongren Boya plasmapheresis Co., Ltd. was established on August 8, 2007, and its legal representative is Xu Jing. The state of the enterprise is in business, with a registered capital of 50.0000000 yuan and a contribution ratio of 100.00%.

Cheng Nan Jinshan plasmapheresis Co., Ltd., the legal representative of which is Chen Kang, was invested on 2006- 12-27, and the enterprise status is in operation (opening), with a registered capital of 700.00000000 and a contribution ratio of 100.00%.

Shenzhen Gaotejia Qianhai You Xiang Investment Partnership (Limited Partnership), the legal representative is Shenzhen Gaotejia Investment Group Co., Ltd. (authorized representative: thomas lee), the date of investment is 2014-131,the enterprise status is open, and the registered capital is 381500.

Du Yu Boya plasmapheresis Co., Ltd., the legal representative is Cheng Xiangjiao, the date of contribution is 20 16-0 1-22, the enterprise status is in operation (opening), the registered capital is 1000.000000, and the contribution ratio is100.00.

Xinfeng plasmapheresis co., ltd, whose legal representative is Zhang organ, was invested on 20 15-0 1-22, and its enterprise status was in business, with a registered capital of/kloc-0 1000.000000 and a contribution ratio of 100.00%.

Shareholders:

Shenzhen Ronghua Investment Co., Ltd. contributed 65,438+0.53%, and the subscribed capital contribution was 664,438+0.20 million.

The investment ratio of Xiamen Shengyang Investment Partnership (Limited Partnership) is 65,438+0.23%, and the subscribed capital contribution is 532.8+00000.

Xiamen Shunjia Investment Partnership (Limited Partnership) contributed 0.82%, and the subscribed capital contribution was 354,400 yuan.

Zhang Jianhui contributed 0.5 1%, and the subscribed contribution was 22 1.795600.

Xu Jianxin, the contribution ratio is 0.5 1%, and the subscribed contribution is 222.38+000.

The contribution ratio of Nanchang Dazheng Chu Yuan Investment Co., Ltd. is 0.4 1%, and the subscribed capital contribution is 177.436600.

The investment ratio of Shenzhen Gaotejia Huifu Investment Partnership (Limited Partnership) is 0.4 1%, and the subscribed capital contribution is 177.46700.

The investment ratio of Shenzhen Gaotejia Investment Group Co., Ltd. is 6. 14%, and the subscribed capital contribution is 266 1.547300.

Social common stock (A shares), with a capital contribution ratio of 4.39%, and the subscribed capital contribution is 1902.438+05438+000.

Jiangxi Xinxing Biotechnology Development Co., Ltd. contributed 1.54%, and the subscribed capital contribution was 665.6900 yuan.

Executives:

Tan Guiling is in charge of the company.

Liao Xinxi is the chairman of the company.

Wu Xiaoming is a director of this company.

Xu Jianxin is a director of our company.

Zeng Xiaojun is a director of our company.

Zhao Huanqi is a director of this company.

Jiang Guoliang is in charge of this company.

Song is a director of the company.

Ouyang Pingkai is in charge of the company.

Fan is a director of the company.